Loading company…
Austin-based Molecular Templates, Inc. develops engineered toxin bodies for targeted cancer treatment.
Established in 2001 and headquartered in Austin, Texas, Molecular Templates, Inc. is a clinical-stage biopharmaceutical company developing engineered toxin bodies designed to destroy cancer cells while sparing healthy tissue. Its pipeline includes candidates in clinical trials, and it works with pharmaceutical companies and research institutions. The company has raised USD 20.00 mn in total across 18 deals, most recently a PIPE on July 20, 2020, led by BVF Partners with investors including Adage Capital Management and BB Biotech.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in